Hello! Interesting, niche, question from one of our safety-minded outpatient pharmacists regarding the medication Trikafta (elexacaftor, tezacaftor, ivacaftor) for management of CF.

Curious if anyone else has come up with a solution to safely / accurately prescribe and document this medication when dose adjustments are indicated.

This med is supplied as 2 separate products packaged together in a blister card package containing 21 tablets: elexacafter/tezacaftor/ivacaftor (orange capsule-shaped tablet) in fixed-dose combination and ivacaftor (blue capsule-shaped tablets)